Spaulding Rehabilitation Hospital
Boston, Massachusetts, 02129, United States
NCT Number: NCT03965403
The overall objective of the proposed study is to carry out usability and design-evaluation assessments of the BURT robotic device for delivering long-term intervention in stroke survivors. The BURT is an upper extremity robotic device that enables the user to see and feel engaging games that encourage intensive therapy. The investigators intend to recruit up to 10 stroke survivors over the course of the study. Participants will train their arm with the BURT for 18 sessions over approximately 6 weeks then participate in a question/answer formatted discussion with research staff to discuss the usability of the device. The investigators will also assess participant's arm function at baseline and after the training sessions.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02129, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention will be focused on patients impairments to assess the feasibility of the BURT device to carry-on long interventions
Time frame: 6 weeks
Assessment of upper extremity impairments. Individual items of the scale are summed for a total score ranking from 0 to 66. Higher scores indicate better outcomes.
Time frame: 6 weeks
Standardized measure of goals selection and scaling to calculate the extend to which the participant's goals are met.
The Goal Attainment Scale ranges from -2 to +2. Positive scores indicates goals are better than expected, score of 0 indicates goals are met and negative scores indicates goals aren't met.
Time frame: 6 weeks
Assessment of upper-extremity function by the performance time of the Wolf Motor Function Test). The average of the 15 items is reported. The time ranges from 0 to 120 seconds. A decrease in performance time is associated with improved upper-extremity function.
Time frame: 6 weeks
Use of upper extremity in daily life. The self-reported amount of use is reported on a scale from 0 to 5. A score of zero is assigned when the hemiparetic side is not used during the activity of daily living, a score of 5 is assigned when the hemiparetic side is used as much as before the stroke. The 30 items of the scale are averaged. Higher scores are a sign of better use in daily life.
Time frame: 6 weeks
Assessment of muscle tone for upper extremity muscles. Score rank from 0 (no tone) to 4 (no movement possible). Lower scores indicates a better outcome.
Tone at the shoulder and elbow were measured
Time frame: 6 weeks
Assessment of active arm range of motion with goniometry. Results are reported in degrees and higher ranges include better outcomes.
Time frame: 6 weeks
Assessment of arm muscle strength using the manual muscle testing scale ranking from 0 (no contraction) to 10 (maximal strength). Higher scores indicate better outcomes.
Time frame: 6 weeks
Assessment of upper-extremity function with the Functional ability subscale of the Wolf Motor Function Test.
The average of the 15 items is reported. Scores ranges from 0 to 5, they rate the quality of the movement performance. 0= do not attempt, up to 5= identical to contralateral side. Higher scores are associated with better movement quality.
Spaulding Rehabilitation Hospital
Other
Upper Extremity Rehabilitation With the BURT Robotic Arm: a Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01573585
Brain Diseases, Cardiovascular Diseases
North Vancouver, British Columbia, Canada
View Trial DetailsNCT07002463
Brain Diseases, Cardiovascular Diseases
Wroclaw, Poland
View Trial DetailsNCT05590988
Brain Diseases, Cardiovascular Diseases
Hessisch Oldendorf, Lower Saxony, Germany
View Trial DetailsNCT02418949
Brain Diseases, Cardiovascular Diseases
Chicago, Illinois, United States
View Trial Details